Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells
- PMID: 19284328
- PMCID: PMC2958436
- DOI: 10.1089/jop.2008.0098
Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells
Abstract
Purpose: Nearly all eye drops contain preservatives to decrease contamination. Nonpreservatives such as disodium-ethylene diamine tetra-acetate (EDTA) and phosphate-buffered saline are also regularly added as buffering agents. These components can add to the toxicity of eye drops and cause ocular surface disease. To evaluate the potential toxicity of these common components and their comparative effects on the ocular surface, a tissue culture model utilizing immortalized corneal and conjunctival epithelial cells was utilized.
Methods: Immortalized human conjunctival and corneal epithelial cells were grown. At confluency, medium was replaced with 100 microL of varying concentrations of preservatives: benzalkonium chloride (BAK), methyl paraben (MP), sodium perborate (SP), chlorobutanol (Cbl), and stabilized thimerosal (Thi); varying concentrations of buffer: EDTA; media (viable control); and formalin (dead control). After 1 h, solutions were replaced with 150 microL of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazonium bromide). After 4 h, solutions decanted, 100 microL of acid isopropanol added, and the optical density determined at 572 nm to evaluate cell viability.
Results: Conjunctival and corneal cell toxicity was seen with all preservatives. Depending upon concentration, BAK exhibited from 56% to 89% toxicity. In comparison, Cbl exhibited from 50% to 86%, MP from 30% to 76%, SP from 23% to 59%, and Thi from 70% to 95%. EDTA with minimal toxicity (from 6% to 59%) was indistinguishable from SP.
Conclusions: Generally, the order of decreasing toxicity at the most commonly used concentrations: Thi (0.0025%) > BAK (0.025%) > Cbl (0.25%) > MP (0.01%) > SP (0.0025%) approximately EDTA (0.01%). Even at low concentration, these agents will cause some degree of ocular tissue damage.
Figures

Similar articles
-
N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study.Cutan Ocul Toxicol. 2018 Mar;37(1):71-76. doi: 10.1080/15569527.2017.1347942. Epub 2017 Jul 18. Cutan Ocul Toxicol. 2018. PMID: 28658977
-
Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells.Clin Exp Ophthalmol. 2008 Aug;36(6):553-9. doi: 10.1111/j.1442-9071.2008.01803.x. Clin Exp Ophthalmol. 2008. PMID: 18954319
-
Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells.J Ocul Pharmacol Ther. 2009 Oct;25(5):415-24. doi: 10.1089/jop.2008.0140. J Ocul Pharmacol Ther. 2009. PMID: 19857103 Free PMC article.
-
Effects of common ophthalmic preservatives on ocular health.Adv Ther. 2001 Sep-Oct;18(5):205-15. doi: 10.1007/BF02853166. Adv Ther. 2001. PMID: 11783457 Review.
-
Ocular preservatives: associated risks and newer options.Cutan Ocul Toxicol. 2009;28(3):93-103. doi: 10.1080/15569520902995834. Cutan Ocul Toxicol. 2009. PMID: 19505226 Review.
Cited by
-
Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop.Clin Ophthalmol. 2013;7:299-312. doi: 10.2147/OPTH.S40588. Epub 2013 Feb 13. Clin Ophthalmol. 2013. PMID: 23430378 Free PMC article.
-
Lipophilic Arginine Esters: The Gateway to Preservatives without Side Effects.Mol Pharm. 2020 Aug 3;17(8):3129-3139. doi: 10.1021/acs.molpharmaceut.0c00610. Epub 2020 Jul 9. Mol Pharm. 2020. PMID: 32598849 Free PMC article.
-
Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress.J Nanobiotechnology. 2023 Mar 10;21(1):84. doi: 10.1186/s12951-023-01838-x. J Nanobiotechnology. 2023. PMID: 36899348 Free PMC article. Review.
-
Ocular toxicity of benzalkonium chloride homologs compared with their mixtures.J Toxicol Pathol. 2013 Dec;26(4):343-9. doi: 10.1293/tox.2013-0022. Epub 2013 Dec 26. J Toxicol Pathol. 2013. PMID: 24526806 Free PMC article.
-
Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium.Clin Ophthalmol. 2020 Jan 24;14:257-267. doi: 10.2147/OPTH.S229879. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32158183 Free PMC article.
References
-
- Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv.Ther. 2001;18:205–215. - PubMed
-
- Spickett C. Studies of Cellular Responses to Purite and Other Preservatives. Strathclyde, UK: University of Strathclyde; 2001.
-
- Asbell P.A. Fifth 5th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) Monte Carlo: Monaco; Mar 11–14, 2004. Tear Substitutes: Past, Present and Future.
-
- Noecker R. Herrygers L. Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490–496. - PubMed
-
- Noecker R. Protecting the ocular surface in glaucoma and keratoconjunctivitis sicca. A Supplement to Refractive Eyecare® for Ophthalmologists. 2004;8:1–10.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous